Therapeutic Advantages to Using EEG to Assess Alzheimer Agents: Williem de Haan, MD, PhD
October 25th 2023The neurologist and senior research at the Amsterdam University Medical Centers’ Alzheimer Center discussed the reasons behind the use of quantitative EEG in assessing Cognition Therapeutics' Alzheimer agent CT1812. [WATCH TIME: 3 minutes]